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Vascular surgery, currently a mono-
specialty in a large number of countries,
is dedicated to the diagnosis and manage-
ment of all aspects of vascular disease (arte-
rial, venous, and lymphatic), excluding the
heart and brain vessels. Vascular diagno-
sis is complemented by non-invasive tests
that are frequently performed by the man-
aging physician, regardless of the intention
for interventional treatment. Non-invasive
tests, originally limited mainly to vascular
ultrasound but now expanded to include
computed tomography and magnetic res-
onance angiography, have largely reduced
the need for arteriography and its atten-
dant risks, preserving its diagnostic ability,
and even improving preoperative planning
and patient selection.
The dawn of the new millenium found
Vascular Surgery strengthened by the FDA
approval of endografts for endovascular
aneurysm repair (EVAR), a minimally inva-
sive treatment that proved to be a revolu-
tion for the treatment of abdominal aor-
tic aneurysms (AAA). It was clear at that
point that a decade of research was suc-
cessfully translated into clinical practice;
however, the adoption of EVAR was really
supported by trial evidence that became
available the following years (1). Stretch-
ing the anatomical indications of EVAR and
the need for endless follow-up has been a
real challenge, partially addressed by new
types of endografts. Around the same time,
endoluminal vein ablation (ELVA) of the
saphenous veins was also approved. Being
further refined as new minimally invasive
technology is invented, ELVA has replaced
a large number of stripping procedures
worldwide. Other areas where endovascu-
lar techniques have expanded our treat-
ment armamentarium include the periph-
eral arteries, in order to prevent limb
loss, deterioration of quality of life or
death. Drug eluting stents and balloons,
covered stents and improved atherectomy
devices have been introduced into clinical
practice.
An area of active debate is the optimum
management of extracranial carotid artery
stenosis, where endarterectomy is still con-
sidered the standard of care, but judi-
cious use of angioplasty and stenting (CAS)
might improve outcomes in symptomatic
patients. The availability of modern med-
ical treatment has challenged the need for
intervention in most patients with asymp-
tomatic carotid artery stenosis and ran-
domized controlled trials (CREST-2) are
underway. Selective use of intervention in
high-risk groups at a low peri-procedural
risk and with sufficient life expectancy is
required (2, 3).
Vascular surgeons are actively involved
in all kinds of trauma involving the
blood vessels and also when these are
thrombosed, including deep-vein throm-
bosis. The advent of new oral anticoag-
ulants is expected to simplify the man-
agement of venous thromboembolism (4),
but the post-thrombotic syndrome (PTS)
is expected to be a burden for affected
patients, unless pre-emptive thrombus
removal becomes popular (5). Finally, vas-
cular access for hemodialysis has been
improved with efforts toward preferential
construction of native arteriovenous fistu-
las and increased longevity of maintenance
procedures performed for access compli-
cations being fruitful; however, there is
an unmet need for further improvements,
necessary for this challenging patient
population.
The present Specialty Grand Chal-
lenge article officially launches the Vascular
Surgery Section of Frontiers in Surgery.
The goal is to provide a unique open access
forum for publication and rapid dissemi-
nation of important research covering the
entire spectrum of Vascular Surgery.
REFERENCES
1. Greenhalgh RM, Brown LC, Kwong GP, Powell
JT, Thompson SG. Comparison of endovascular
aneurysm repair with open repair in patients with
abdominal aortic aneurysm (EVAR trial 1), 30-day
operative mortality results: randomised controlled
trial. Lancet (2004) 364(9437):843–8. doi:10.1016/
S0140-6736(04)16979-1
2. Nicolaides AN, Kakkos SK, Kyriacou E, Griffin M,
Sabetai M, Thomas DJ, et al. Asymptomatic inter-
nal carotid artery stenosis and cerebrovascular risk
stratification. J Vasc Surg (2010) 52(6):e1–5. doi:10.
1016/j.jvs.2010.07.021
3. Kakkos SK, Griffin MB, Nicolaides AN, Kyri-
acou E, Sabetai MM, Tegos T, et al. The size
of juxtaluminal hypoechoic area in ultrasound
images of asymptomatic carotid plaques predicts
the occurrence of stroke. J Vasc Surg (2013) 57(3):
609e–18e. doi:10.1016/j.jvs.2012.09.045 discussion
17-8,
4. The EINSTEIN. Investigators. Oral rivaroxaban
for symptomatic venous thromboembolism. N
Engl J Med (2010) 363(26):2499–510. doi:10.1056/
NEJMoa1007903
5. Enden T, Haig Y, Klow NE, Slagsvold CE, Sandvik L,
Ghanima W, et al. Long-term outcome after addi-
tional catheter-directed thrombolysis versus stan-
dard treatment for acute iliofemoral deep vein
thrombosis (the CaVenT study): a randomised con-
trolled trial. Lancet (2012) 379(9810):31–8. doi:10.
1016/S0140-6736(11)61753-4
Conflict of Interest Statement: The author declares
that the research was conducted in the absence of any
commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 02 June 2014; accepted: 15 July 2014; published
online: 30 July 2014.
Citation: Kakkos S (2014) Vascular surgery, Quo Vadis?
Front. Surg. 1:30. doi: 10.3389/fsurg.2014.00030
This article was submitted to Vascular Surgery, a section
of the journal Frontiers in Surgery.
Copyright © 2014 Kakkos. This is an open-access arti-
cle distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with
these terms.
www.frontiersin.org July 2014 | Volume 1 | Article 30 | 1
